New month – new faces! Welcome to all new colleagues who joined us at Sartorius' sites around the globe in August. 👋 We’re glad that you are now #PartOfTheSolution and are working together with us to simplify progress in the life sciences and in bioprocessing – so that more people get access to better medicine. Have a good start and lots of enjoyment in your new jobs! 🙌 Would you also like to become part of the solution? 👉 Take a look at our open jobs and apply now: www.sartorius.com/careers #Careers #Onboarding #NewJob #SimplifyingProgress
Sartorius
การวิจัยเทคโนโลยีชีวภาพ
Göttingen, Lower Saxony ผู้ติดตาม 177,545 คน
A Trusted Partner of Life Sciences Research and Biopharmaceutical Manufacturing | #SimplifyingProgress
เกี่ยวกับเรา
Sartorius is a leading international partner of life sciences research and biopharmaceutical manufacturing. We help our customers #SimplifyProgress from drug discovery to manufacturing so that more people can have access to better medicine. With this, we are #PartOfTheSolution in the fight against diseases worldwide. With innovative laboratory instruments and consumables, the our Lab Products & Services division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. The Bioprocess Solutions division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and economically. Based in Göttingen, Germany, Sartorius also has a strong global reach with around 60 production and sales sites worldwide. We regularly expand our portfolio through the acquisition of complementary technologies. In 2023, Sartorius generated sales revenue of around 3.4 billion euros. Currently, around 14,600 employees from around 110 nations are working for customers around the globe. Join our team, partner or collaborate with us.
- เว็บไซต์
-
http://www.sartorius.com
ลิงก์ภายนอกสำหรับ Sartorius
- อุตสาหกรรม
- การวิจัยเทคโนโลยีชีวภาพ
- ขนาดของบริษัท
- พนักงาน 10,001 คนขึ้นไป
- สำนักงานใหญ่
- Göttingen, Lower Saxony
- ประเภท
- บริษัทมหาชน
- ก่อตั้งเมื่อ
- 1870
ตำแหน่งที่ตั้ง
พนักงานที่ Sartorius
อัพเดท
-
Sartorius closed the first half of the year with a positive trend in sales revenue development. Due to the ongoing high volatility and limited predictability, however, the company is now de-risking its outlook for the second half of the year. "Sartorius met its targets for the first half of the year, and we achieved the intended slight sales revenue growth and robust profitability in the second quarter. As in the first three months, the picture remained exceptionally mixed," said CEO Joachim Kreuzburg. "In the medium and long term, the mega topics of #healthcare and #biotechnology remain strong structural drivers for our profitable growth strategy, and the increased volatility caused by the pandemic has not made any difference to this.” ➡️ Moderately positive revenue development in Q2 ➡️ Demand recovery remains muted ➡️ Full-year outlook deliberately more cautious ➡️ Long-term trends in life sciences & biopharma remain positive Read media release: https://lnkd.in/emm-3rNs #SimplifyingProgress
-
Explore the latest technologies and insights at this year's #ProcessIntensification Forum, taking place from September 17-19 in Göttingen, Germany. The event features three days of industry-leading speakers, interactive demonstrations, and networking sessions focused on sharing knowledge and driving progress. With your ticket, you'll gain access to case studies presented by industry leaders, have the chance to tour and test new technologies in our training center, and connect with fellow scientists in your field. Tickets are limited – register soon to take advantage of the early-bird rate. https://sar.to/d0eqs #SimplifyingProgress #InThisTogether #Bioprocess #Biopharma #PIforum2024
-
Sartorius has been recognized with several prizes at the #GermanBrandAward and the #BOB Award💥 The current brand campaign "In this together" was recently successful at the German Brand Award as well as the BOB Best of Business-to-Business Award. Aiming to elevate Sartorius's brand awareness and familiarity in the Life Science and Biopharma markets, the campaign features bold illustrations, a compelling video and emphasizes our commitment to our customers’ success. Whether it's accelerating research, enhancing production efficiency to deliver new medicines to patients faster, or advancing sustainability goals, we stand with our customers every step of the way to help them simplify progress. For this year's awards, the German Design Council had received more than 1,200 submissions. The Sartorius brand strategy and campaign were successful in these categories: 🏆 »Gold« for Sartorius Brand in the category Excellence in Brand Strategy and Creation: Brand Strategy – B2B 🏆 »Best of Best« for Sartorius Brand Campaign Manifesto Film in the category Excellence in Brand Strategy and Creation: Lighthouse Project of the Year 🏆 »Gold« for Sartorius Brand Campaign Manifesto Film in the category Excellence in Brand Strategy and Creation: Brand Communication – Movies, Commercials & Virals At the BoB Award, which focuses on B2B communication, Sartorius received 🏆 Silver in the category "Crossmedia & Integrated Campaigns". Watch the full video: https://ow.ly/1WrN50SyIGN #SimplifyingProgress #InThisTogether #LifeScience #Biopharma #BrandStrategy
-
Transforming water use in filter production: Potential to save over 50 million liters annually. Filter production demands significant amounts of purified water. Ghiath Wahbi, Project Manager for Separation Technologies, and his team introduced a prototype for a water recycling system for filter production, enabling the reuse of the vital resource. This invention can not only conserve water but also reduce energy costs and carbon emissions. Discover more about this innovative project on the Sartorius blog: https://ow.ly/pq4v50SwSVC #Sustainability #Water #Recycling #SimplifyingProgress
-
Heart failure affects an estimated 40 to 60 million individuals globally. Find out how Sartorius and the biotech company Repairon are #InThisTogether for a cure 🤝💛 Shortly after birth, our heart muscle cells lose their ability to divide. This means that damage such as a heart attack leads to an irreversible loss of these cells. As a result, the heart's ability to pump effectively decreases, which can lead to heart failure. For over two decades, the team at Repairon has been researching to develop the so-called heart patch. This new heart tissue is artificially grown from stem cells in the lab and then sewn onto special membranes compatible with the human body. ❤️🩹 ➡️ Discover how Sartorius supports Repairon in the production of stem cells for heart patches on the Sartorius Blog: https://ow.ly/gPXZ50Svinq #SimplifyingProgress #PartOfTheSolution #HeartFailure #HeartPatch #Production
-
Recapping #PrideMonth!🌈 As June, dedicated to celebrating the LGBTQ+ community, comes to an end, we would like to spotlight the activities that employee resource groups at Sartorius organized and hosted. 🌟 Highlights of this year��s Pride Month: - Participation in the Long Island Pride Parade - Pride Celebration and Employee Appreciation Party - Virtual Panel Discussion with participants from Sartorius’ sites around the world All events had one goal: to focus on the LGBTQ+ community, raise awareness of their challenges, and promote a culture of diversity, equity, belonging, and inclusion within the company. Read more about the events on the Sartorius blog: https://sar.to/njtvo #LGBT #PrideMonth #Diversity #DEIB
-
-
Have you ever heard of the mosquito-borne chikungunya virus? According to the WHO, more than two million cases of chikungunya infections, which cause flu-like symptoms and severe joint pain, have been reported since 2005. No vaccine was available against the virus – until Sartorius’ customer Valneva had their vaccine approved by the FDA in late 2023. Learn more on the Sartorius blog about how we are part of the solution and how recombinant albumin from Albumedix now a part of Sartorius, stabilizes the vaccine during storage and transport: https://sar.to/voytu #PartOfTheSolution #SimplifyingProgress #Bioprocessing #BetterHealth
Part of the Solution: How Recombinant Albumin Supports the World’s First Chikungunya Vaccine
-
🔬 Did you know that mitochondria, the powerhouse of our cells, are inherited from our mothers? These tiny organelles are not just crucial for our health but also play a significant role in cancer. Cancer cells rely on mitochondria for energy, especially in harsh environments where nutrients are scarce. Mitochondria help these cells by producing ATP, a more efficient energy source than glycolysis. This process is key for tumor growth and survival. Understanding the intricate dance between cancer cells and mitochondria is vital. It sheds light on how tumors resist drugs and continue to thrive. Learn more about the world of cellular energy and cancer resilience - download the infographic: https://ow.ly/7N9c50Soprv Follow Incucyte® - Live-Cell Analysis Systems to find out more about observing and quantifying complex biological changes in real-time. #SimplifyingProgress #CancerResearch #Mitochondria #CellBiology #Cancer #livecellimaging
-
Is time of the essence? The clocks are ticking louder for scientists and engineers researching new treatments for cancer, genetic disorders, and the pandemics of tomorrow. Moving quickly from discovering to delivering biological therapeutics can make or break its success. Sartorius’ single-use technologies are a speed boost, cutting production time and costs, while enhancing flexibility. This empowers research teams around the world to simplify and accelerate progress in life science and bioprocessing. We’re in this together. Expedite your drug to market through rapid deployment of single-use solutions. Discover our scalable single-use technologies at www.sartorius.com #SimplifyingProgress #LifeSciences #bioprocessing #InThisTogether